NCT00496990已完成2 期
Treating the Partners of Drug Using Pregnant Women: Stage II
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 158
- 试验地点
- 2
- 主要终点
- Partner Objective Substance Use
研究概览
简要总结
This is a two group randomized design that will compare a novel therapy package (i.e., Research supported treatment intervention, Contingency-based voucher incentives for the male partner's drug abstinence, Specialized MI couples counseling) to standard care for helping drug using partners of drug dependent pregnant women obtain and maintain drug abstinence. Participants will be followed for 22 weeks and have scheduled twice weekly urine sample collection and all participants will have follow-up interviews post-study entry.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 60 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •are 18 years of age or older on admission;
- •Pregnant as determined by sonogram results
- •have a current sexual partner who they have seen recently at least 3 times a week
- •male partner has regular alcohol or illicit drug use (at least 4 of 7 days typical use) and is not incarcerated.
排除标准
- •woman or partner report current suicidal ideation
- •woman or partner meet diagnostic criteria for a current DSM-IV Axis I thought disorder (i.e. schizophrenia)
- •woman or partner demonstrate significant cognitive impairment that precludes them from completing the initial assessment battery
- •woman has evidence of physical violence or abuse
结局指标
主要结局
Partner Objective Substance Use
时间窗: treatment entry until 28 weeks later
次要结局
- Woman's drug use will be measured with urine toxicology(treatment entry until 28 weeks later)
研究者
Hendree E. Jones
Adjunct Professor
Johns Hopkins University
研究点 (2)
Loading locations...
相似试验
已完成
2 期
Biological Sling Allograft (UVT) for the Treatment of Urinary Incontinence in Women Presenting With Synthetic Sling ComplicationsFemale Stress IncontinenceStress Urinary IncontinenceNCT05207189TBF Genie Tissulaire16
Unknown
2 期
A Study of Lidocaine Pertubation as a Treatment for Unexplained InfertilityUnexplained InfertilityNCT03386552Isifer AB120
已完成
3 期
Assessment of Multiple Intrauterine Gestations From Ovarian StimulationPregnancyUnexplained InfertilityNCT01044862Yale University900
已完成
4 期
Safety of RIV4 Versus IIV4 in Pregnant WomenSafetyAdverse Event Following ImmunisationBirth OutcomesNCT03969641Duke University384
已完成
1 期
Reducing HIV Risk Among Pregnant Women in Drug TreatmentHIV Risk BehaviorNCT00332813Rhode Island Hospital98